EMA considers azithromycin heart warning
15:02 EDT 15 Mar 2013 | Pharmaceutical Journal
The European Medicines Agency is considering whether to strengthen warnings about the risk of potentially fatal arrhythmias in azithromycin prescribing information. A safety announcement was issued by the US Food and Drug Administration this week (1..
Original Article: EMA considers azithromycin heart warning
More From BioPortfolio on "EMA considers azithromycin heart warning"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
